Health Resources and Services Administration

Description

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.

Who can apply

• State governments
• Unrestricted

Contact

Nordia Williams<br/>nwilliams1@hrsa.gov
nwilliams1@hrsa.gov